Zinc Chemoprevention of Arsenic Co-Carcinogenesis
锌对砷协同致癌作用的化学预防
基本信息
- 批准号:9325454
- 负责人:
- 金额:$ 31.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffinityAntioxidantsArsenicArsenitesBase Excision RepairsBenzo(a)pyreneBindingBiochemicalBiological AssayCadmiumCarcinogensCellsChemopreventionChemoprotectionChemoprotective AgentChromiumCoupledCysteineDNA BindingDNA Binding DomainDNA DamageDNA RepairDNA Repair GeneDNA Repair InhibitionDNA Repair PathwayDNA Sequence AlterationElementsEmployee StrikesEpidemiologyFoodFoundationsGoalsHumanIntakeMalignant neoplasm of lungMalignant neoplasm of urinary bladderMeasuresMetalsMethodsMolecular TargetMusMutagenesisNucleotide Excision RepairOutcomeOutcome StudyPathway interactionsPlayPoly(ADP-ribose) PolymerasesPopulationPrevention strategyProteinsPublishingRadiation Induced DNA DamageReportingResearchRiskRoleSkinSkin CancerSkin CarcinogenesisSkin NeoplasmsSmokingSoilSolidSun ExposureTestingUV inducedUltraviolet RaysWaterWorkXeroderma PigmentosumZincZinc FingersZinc supplementationbasecarcinogenesiscarcinogenicitycostenzyme activityepidemiologic dataexperimental studyexposed human populationfunctional restorationgenome integritygenotoxicityimprovedin vivoinnovationnoveloxidative DNA damagepreventpublic health relevancerepairedsynergismsynthetic peptidetumorigenesis
项目摘要
DESCRIPTION (provided by applicant): There is strong evidence that in addition to the known direct carcinogenic actions of high arsenic concentrations, low, non-carcinogenic levels of arsenic synergize with other DNA-damaging agents such as benzo[a]pyrene and ultraviolet radiation (UVR) to enhance carcinogenesis. This observation has led to the identification of arsenic as a co-carcinogen. One mode of action to account for arsenic co-carcinogenesis is inhibition of DNA repair proteins containing zinc finger DNA binding motifs. Research from our lab demonstrates that: i) zinc finger proteins with e3 cysteine residues are direct molecular targets for arsenite binding, including xeroderma pigmentosum group A (XPA) and poly(ADP-ribose)polymerase (PARP)-1, which are the critical proteins for nucleotide excision repair (NER) and base excision repair (BER) respectively; ii) low levels of arsenite enhance UVR-induced photoproducts and oxidative DNA damage; and iii) supplemental zinc prevents arsenite effects on PARP-1 inhibition, enhancement of UVR-induced DNA damage and mutations. We hypothesize that zinc supplement will prevent arsenite enhancement of UVR-induced skin tumors by restoring the DNA repair capabilities in both BER and NER pathways. The proposed study will address a novel mechanism by which zinc may act to prevent arsenic-augmented carcinogenesis through interaction with distinct molecular targets in DNA repair pathways. In Aim 1, we will use multiple analytical approaches to definitively examine the competitive interaction of arsenite and zinc with synthetic peptides representing the PARP-1 and XPA zinc finger domains and with purified protein. These findings will be coupled with functional assays to establish the consequences of any identified differences in arsenite affinity for target proteins and zinc interactions. Aim 2 will analyze PARP-1 and XPA isolated from treated cells to measure arsenic and zinc binding to protein and the corresponding functional consequences to reveal the specific mechanism by which zinc reverses the arsenic effects. In Aim 3, we will validate PARP-1 and XPA as arsenic targets in vivo using biochemical methods, and test the hypothesis that zinc will prevent arsenic enhancement of UVR-induced DNA damage and skin tumors. The outcomes from the proposed studies are expected to demonstrate the capability of zinc to restore PARP-1 and XPA activity leading to improved genomic integrity and a decrease in the arsenic contribution to co-carcinogenesis. Although zinc has been considered chemoprotective largely through its reported general antioxidant activities, this proposal is innovative by focusing on a novel mechanism by which zinc prevents arsenite binding with specific zinc finger DNA repair protein targets, thus reversing the arsenite inhibition of DNA repair. This study will provide the solid foundations for a clear mechanistic understanding of how supplemental zinc reduces arsenic co-carcinogenesis, and provide the proof of principle for the potential of zinc supplement to prevent arsenic co-carcinogenesis. If validated, supplemental zinc could represent a low cost and easily implemented strategy for chemoprevention in arsenic exposed populations.
描述(由申请人提供):有强有力的证据表明,除了已知的高浓度砷具有直接致癌作用外,低浓度、非致癌水平的砷还可与其他 DNA 损伤剂(如苯并[a]芘)和紫外线辐射 (UVR) 协同作用,从而增强致癌作用。这一观察结果导致砷被鉴定为一种共同致癌物。砷协同致癌的一种作用方式是抑制含有锌指 DNA 结合基序的 DNA 修复蛋白。我们实验室的研究表明: i) 带有 e3 半胱氨酸残基的锌指蛋白是亚砷酸盐结合的直接分子靶点,包括 A 组着色性干皮病 (XPA) 和聚(ADP-核糖)聚合酶 (PARP)-1,它们分别是核苷酸切除修复 (NER) 和碱基切除修复 (BER) 的关键蛋白; ii) 低水平的亚砷酸盐增强了 UVR 诱导的光产物和氧化 DNA 损伤; iii) 补充锌可防止亚砷酸盐对 PARP-1 抑制、增强 UVR 诱导的 DNA 损伤和突变的影响。我们假设锌补充剂将通过恢复 BER 和 NER 途径中的 DNA 修复能力来防止亚砷酸盐增强 UVR 诱导的皮肤肿瘤。拟议的研究将探讨一种新机制,通过该机制,锌可以通过与 DNA 修复途径中的不同分子靶标相互作用来预防砷增强的致癌作用。在目标 1 中,我们将使用多种分析方法来明确检查亚砷酸盐和锌与代表 PARP-1 和 XPA 锌指结构域的合成肽以及纯化蛋白质的竞争性相互作用。这些发现将与功能测定相结合,以确定亚砷酸盐对目标蛋白的亲和力和锌相互作用的任何已识别差异的后果。目标 2 将分析从处理细胞中分离的 PARP-1 和 XPA,以测量砷和锌与蛋白质的结合以及相应的功能后果,以揭示锌逆转砷效应的具体机制。在目标 3 中,我们将使用生化方法验证 PARP-1 和 XPA 作为砷的体内靶标,并检验锌会阻止砷增强 UVR 诱导的 DNA 损伤和皮肤肿瘤的假设。拟议研究的结果预计将证明锌恢复 PARP-1 和 XPA 活性的能力,从而改善基因组完整性并减少砷对协同致癌作用的影响。尽管锌主要通过其报道的一般抗氧化活性被认为具有化学保护作用,但该提案具有创新性,它关注的是一种新机制,通过该机制,锌可以防止亚砷酸盐与特定的锌指 DNA 修复蛋白靶标结合,从而逆转亚砷酸盐对 DNA 修复的抑制。这项研究将为清楚地了解补充锌如何减少砷协同致癌的机制提供坚实的基础,并为补充锌预防砷协同致癌的潜力提供原理证明。如果得到验证,补充锌可能代表一种低成本且易于实施的砷暴露人群化学预防策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURIE G HUDSON其他文献
LAURIE G HUDSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURIE G HUDSON', 18)}}的其他基金
Illuminating the functions and translational potential of CDC42BP/MRCK kinases in ovarian cancer
阐明 CDC42BP/MRCK 激酶在卵巢癌中的功能和翻译潜力
- 批准号:
10216717 - 财政年份:2021
- 资助金额:
$ 31.44万 - 项目类别:
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
综合环境暴露的突变特征:砷和紫外线辐射
- 批准号:
10844717 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别:
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
综合环境暴露的突变特征:砷和紫外线辐射
- 批准号:
10330581 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别:
Biomarkers and mechanisms of metal and mixed metal exposures
金属和混合金属暴露的生物标志物和机制
- 批准号:
10707512 - 财政年份:2017
- 资助金额:
$ 31.44万 - 项目类别:
Biomarkers and mechanisms of metal and mixed metal exposures
金属和混合金属暴露的生物标志物和机制
- 批准号:
10353202 - 财政年份:2017
- 资助金额:
$ 31.44万 - 项目类别:
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
锌对砷协同致癌作用的化学预防
- 批准号:
8762020 - 财政年份:2014
- 资助金额:
$ 31.44万 - 项目类别:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
砷与 UVR 的协同致癌作用:目标蛋白的亚硝化和氧化
- 批准号:
8856568 - 财政年份:2012
- 资助金额:
$ 31.44万 - 项目类别:
Capitalizing on NSAID enantiomer selectivity for cancer prevention and therapy(PQ
利用 NSAID 对映体选择性进行癌症预防和治疗 (PQ
- 批准号:
8625502 - 财政年份:2012
- 资助金额:
$ 31.44万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 31.44万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




